tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

GB:AZN Stock Latest News

AstraZeneca price target raised to 11,700 GBp from 11,300 GBp at Jefferies
The FlyAstraZeneca price target raised to 11,700 GBp from 11,300 GBp at Jefferies
3d ago
AZN
AstraZeneca Shares Update and Global Reach
PremiumCompany Announcements
AstraZeneca Shares Update and Global Reach
4d ago
AstraZeneca’s MAA for sipavibart accepted by EMA for COVID-19 prevention
PremiumThe Fly
AstraZeneca’s MAA for sipavibart accepted by EMA for COVID-19 prevention
4d ago
AZN
AstraZeneca’s Imfinzi, Lynparza recommended for approval in EU by CHMP
PremiumThe Fly
AstraZeneca’s Imfinzi, Lynparza recommended for approval in EU by CHMP
4d ago
AZN
AstraZeneca’s Cancer Treatments Set for EU Approval
PremiumCompany Announcements
AstraZeneca’s Cancer Treatments Set for EU Approval
4d ago
AstraZeneca says Tagrisso with addition of chemo approved in China for NSCLC
PremiumThe FlyAstraZeneca says Tagrisso with addition of chemo approved in China for NSCLC
9d ago
AZN
UK Stocks: AstraZeneca’s (AZN) Imfinzi Disappoints in Advanced Lung Cancer Trial
PremiumGlobal Markets
UK Stocks: AstraZeneca’s (AZN) Imfinzi Disappoints in Advanced Lung Cancer Trial
10d ago
AZN
AstraZeneca’s Imfinzi demonstrated statistically significant improvement
PremiumThe Fly
AstraZeneca’s Imfinzi demonstrated statistically significant improvement
10d ago
AZN
AstraZeneca’s Tagrisso approved in Japan for 1st-line treatment
PremiumThe Fly
AstraZeneca’s Tagrisso approved in Japan for 1st-line treatment
10d ago
AZN
AstraZeneca says ADJUVANT BR.31 Phase III trial did not achieve primary endpoint
PremiumThe Fly
AstraZeneca says ADJUVANT BR.31 Phase III trial did not achieve primary endpoint
10d ago
AZN
AstraZeneca’s Imfinzi Boosts Bladder Cancer Survival
PremiumCompany Announcements
AstraZeneca’s Imfinzi Boosts Bladder Cancer Survival
10d ago
AstraZeneca’s Imfinzi Misses Phase III Trial Goal
PremiumCompany Announcements
AstraZeneca’s Imfinzi Misses Phase III Trial Goal
10d ago
AstraZeneca reports Truqap plus Faslodex approved in EU for breast cancer
PremiumThe FlyAstraZeneca reports Truqap plus Faslodex approved in EU for breast cancer
15d ago
AZN
AstraZeneca reports CAPItello-290 Phase 3 trial did not meet primary endpoints
PremiumThe Fly
AstraZeneca reports CAPItello-290 Phase 3 trial did not meet primary endpoints
17d ago
AZN
AstraZeneca’s Truqap Trial Misses Endpoints
PremiumCompany Announcements
AstraZeneca’s Truqap Trial Misses Endpoints
17d ago
AstraZeneca: IMFINZI +chemo gets approval for endometrial cancer with dMMR
PremiumThe Fly
AstraZeneca: IMFINZI +chemo gets approval for endometrial cancer with dMMR
18d ago
AZN
AstraZeneca reports Imfinzi plus chemo approved for endometrial cancer in U.S.
PremiumThe Fly
AstraZeneca reports Imfinzi plus chemo approved for endometrial cancer in U.S.
18d ago
AZN
FDA Approves AstraZeneca’s Imfinzi for Endometrial Cancer
PremiumCompany Announcements
FDA Approves AstraZeneca’s Imfinzi for Endometrial Cancer
18d ago
AstraZeneca announces results from ECHO Phase III trial
PremiumThe Fly
AstraZeneca announces results from ECHO Phase III trial
19d ago
AZN
AstraZeneca’s Farxiga approved by FDA to treat pediatric diabetes
PremiumThe FlyAstraZeneca’s Farxiga approved by FDA to treat pediatric diabetes
23d ago
AZN
AstraZeneca CEO Gifts Shares to Family
PremiumCompany Announcements
AstraZeneca CEO Gifts Shares to Family
23d ago
AstraZeneca price target raised to 15,000 GBp from 13,000 GBp at Berenberg
PremiumThe Fly
AstraZeneca price target raised to 15,000 GBp from 13,000 GBp at Berenberg
25d ago
AZN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >